ArticleJTO clinical and research reports2022

Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (

Shannon S Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.